U.S – bioMérieux, a global pioneer in in-vitro diagnostics, has developed a first-of-its-kind testing kit that simultaneously detects Listeria and Salmonella from environmental swabs, with PCR confirmation.
The technology reduces laboratory waste, lowers costs, and streamlines the workflow to enable quick and accurate quality decisions.
Separate enrichments are used in the market-available processes and tests for Salmonella and Listeria.
With the help of GENE-UP ENVIROPRO, users may test environments for both Salmonella and Listeria with just one swab, one enrichment, and one sample preparation, increasing total sampling efficiency and sustainability.
The GENE-UP ENVIROPRO assay is the outcome of bioMérieux’s xPRO program, an innovation engine within bioMérieux that collaborates directly with industry leaders to quickly develop, validate, and commercialize cutting-edge molecular assay to address new market needs and improve their overall quality programs.
“The evolution of ENVIROPRO demonstrates our commitment to innovation through our xPRO program and our success in building game-changing assays.
“Bringing much-needed efficiencies to routine environmental monitoring will not only reduce costs for our end users but do so in a far more sustainable way, a key focus in the market,” said Ben Pascal, Global Head xPRO Program, bioMérieux.
With a best-in-class workflow that does away with time-consuming DNA purification steps and minimizes hands-on time, GENE-UP ENVIROPRO is made to enable rapid and efficient quality decisions.
The solution is an AOAC Performance Tested Method that may be used for a variety of food sector verticals, with applicability for dairy, dry fruits, nuts, seeds, berries, nutraceuticals, and multicomponent goods among others (e.g., ready-to-eat meals).
After the debut of the GENE-UP QUANT Salmonella innovation, which was chosen as the method of choice for Salmonella enumeration in the USDA’s Food Safety Inspection Service (FSIS) labs this summer, GENE-UP ENVIROPRO is the newest innovation supporting food safety to enter the market for bioMérieux this year.
“The introduction of these innovative assays marks an important step forward for the food industry, as they provide more detailed data and results in less time to enhance decision-making throughout the production process.
“We look forward to continued collaboration with our customers and partners to identify the existing and emerging issues that threaten food safety to develop solutions that not only meet these needs but improve public health worldwide,” said Miguel Villa, Vice President of Industry Americas at bioMérieux.
With the help of GENE-UP ENVIROPRO, users may test environments for both Salmonella and Listeria with just one swab, one enrichment, and one sample preparation, increasing total sampling efficiency and sustainability.
With a vast network of distributors, bioMérieux, a global leader in in vitro diagnostics for more than 55 years, is present in 45 nations and provides services to more than 160 nations.
Revenues were €3.4 billion (U.S$3.7 billion) in 2021, with more than 93% of sales coming from abroad (outside of France).
